PUBLISHER: Grand View Research | PRODUCT CODE: 1446552
PUBLISHER: Grand View Research | PRODUCT CODE: 1446552
The global biomaterial wound dressing market is expected to reach USD 10.21 billion by 2030, registering a CAGR of 7.46% in the forecast period, according to a new report by Grand View Research, Inc. Advances in biomaterial technology, which have led to the development of innovative and effective wound care products, rising prevalence of chronic diseases, improving healthcare infrastructure in emerging economies, are the key driving factors propel the biomaterial wound dressing market over the forecast period.
Moreover, the biomaterial wound dressing market has seen significant growth over the last few decades, owing to increasing product launches by key players, and rising R&D activities. For instance, in January 2023, Convatec introduced ConvaFoam, a range of advanced foam dressings that cater to the requirements of both healthcare providers and patients. ConvaFoam's versatility makes it an ideal dressing option for managing wounds and safeguarding the skin, as it can be used for various wound types, regardless of the wound's healing stage.
Similarly, in August 2023, Medela launched the Invia Integrated Dressing, which is designed to cater to all types of wounds, including closed surgical incisions. The sterile dressing can be utilized in both hospital and home settings for a period of up to seven days. As a result, product launches with additional benefits are expected to increase market growth for these biomaterial wound dressings over the projection period.
The rising prevalence of chronic disorders, such as diabetes and obesity has led to an increase in the number of patients with chronic wounds. Biomaterial wound dressings have been found to be effective in treating these wounds, which has driven demand for these products. For instance, according to WHO, in 2023, diabetes is a global health concern, with approximately 422 million people affected globally, mostly in low- and middle-income countries. Every year, 1.5 million deaths are directly linked to diabetes. The prevalence and number of cases of diabetes have been on a steady rise over the past few decades. These factors are expected to drive market growth over the forecast period.